Biotechs baby boom. 2018 was the year when the funding machine for privately held biotech companies went into overdrive with megarounds and rapid flotations. JohnNHodgson brings us this deep dive httpsgo.nature.com2VgMU7aÂpic.twitter.com4bVIS

Biotech’s baby boom. 2018 was the year when the funding machine for privately held biotech companies went into overdrive, with mega-rounds and rapid flotations. @JohnNHodgson brings us this deep dive https://go.nature.com/2VgMU7a pic.twitter.com/4bVIS

12:24 EDT 6 May 2019 | Nature Publishing

Biotech’s baby boom. 2018 was the year when the funding machine for privately held biotech companies went into overdrive, with mega-rounds and rapid flotations. @JohnNHodgson brings us this deep dive https://go.nature.com/2VgMU7a pic.twitter.com/4bVISbJtFg

More From BioPortfolio on "Biotech’s baby boom. 2018 was the year when the funding machine for privately held biotech companies went into overdrive, with mega-rounds and rapid flotations. @JohnNHodgson brings us this deep dive https://go.nature.com/2VgMU7a pic.twitter.com/4bVIS"